% alzhub.org library filter % Source: https://alzhub.org/research?author=Talbot+K % 7 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{hu2014-24395708, author = {Hu, M. T. and Szewczyk-Królikowski, K. and Tomlinson, P. and Nithi, K. and Rolinski, M. and Murray, C. and Talbot, K. and Ebmeier, K. P. and others}, title = {{Predictors of cognitive impairment in an early stage Parkinson's disease cohort}}, journal = {Movement disorders : official journal of the Movement Disorder Society}, year = {2014}, doi = {10.1002/mds.25748}, pmid = {24395708}, url = {https://doi.org/10.1002/mds.25748} } @article{menke2014-24951638, author = {Menke, R. A. and Körner, S. and Filippini, N. and Douaud, G. and Knight, S. and Talbot, K. and Turner, M. R.}, title = {{Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis}}, journal = {Brain : a journal of neurology}, year = {2014}, doi = {10.1093/brain/awu162}, pmid = {24951638}, url = {https://doi.org/10.1093/brain/awu162} } @article{rhea2024-38095516, author = {Rhea, E. M. and Babin, A. and Thomas, P. and Omer, M. and Weaver, R. and Hansen, K. and Banks, W. A. and Talbot, K.}, title = {{Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimer's and Parkinson's diseases}}, journal = {Tissue barriers}, year = {2024}, doi = {10.1080/21688370.2023.2292461}, pmid = {38095516}, url = {https://doi.org/10.1080/21688370.2023.2292461} } @article{talbot2014-24529520, author = {Talbot, K. and Wang, H. Y.}, title = {{The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2014}, doi = {10.1016/j.jalz.2013.12.007}, pmid = {24529520}, url = {https://doi.org/10.1016/j.jalz.2013.12.007} } @article{salameh2020-32755557, author = {Salameh, T. S. and Rhea, E. M. and Talbot, K. and Banks, W. A.}, title = {{Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics}}, journal = {Biochemical pharmacology}, year = {2020}, doi = {10.1016/j.bcp.2020.114187}, pmid = {32755557}, url = {https://doi.org/10.1016/j.bcp.2020.114187} } @article{talbot2014-24640977, author = {Talbot, K.}, title = {{Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs}}, journal = {Neurodegenerative disease management}, year = {2014}, doi = {10.2217/nmt.13.73}, pmid = {24640977}, url = {https://doi.org/10.2217/nmt.13.73} } @article{talbot2012-22476197, author = {Talbot, K. and Wang, H. Y. and Kazi, H. and Han, L. Y. and Bakshi, K. P. and Stucky, A. and Fuino, R. L. and Kawaguchi, K. R. and others}, title = {{Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline}}, journal = {The Journal of clinical investigation}, year = {2012}, doi = {10.1172/jci59903}, pmid = {22476197}, url = {https://doi.org/10.1172/jci59903} }